News Ticker

Ansell Introduces World’s First Antiviral Condom To Canadian Market

7ecae8d0-1d48-4768-a3c9-4320db6936c5_1Reposted from

LifeStyles® Dual Protect with VivaGel® lubricant launches on

ISELIN, NJ – Ansell, a global leader in protection solutions and the makers of LifeStyles® and SKYN® Condoms (“SKYN”), announces today the Canada launch of LifeStyles® Dual Protect. The first condom of its kind, Dual Protect features patented VivaGel® lubricant, developed by Starpharma. VivaGel, an innovative antiviral agent, has been proven in laboratory studies to inactivate HIV (human immunodeficiency virus), HSV (herpes simplex virus) and HPV (human papillomavirus).

“At Ansell, safety and innovation have always been at the forefront of our mission, and we pride ourselves on our ability to identify the needs of our consumers and develop innovative products that not only protect users, but enhance the sexual experience,” says Jeyan Heper, President and General Manager, Sexual Wellness Global Business Unit at Ansell. “LifeStyles Dual Protect is a great example of this, and by combining a premium latex condom with Starpharma’s patented antiviral VivaGel technology, Ansell is proud to introduce this first-of-its-kind condom to Canadian consumers.”

According to Canada’s Public Health Agency, STI rates have been rising steadily since the late 1990’s, further exemplifying the need for a product of this kind. VivaGel (SPL7013, or astodrimer sodium) is antiviral and has been proven in laboratory studies to inactivate up to 99.9% of HIV (human immunodeficiency virus), HSV (herpes simplex virus) and HPV (human papillomavirus), which are viruses that cause STIs. LifeStyles Dual Protect is the only condom of its type, providing barrier protection and incorporating the proprietary antiviral VivaGel in the condom lubricant.

Starpharma Chief Executive Officer, Dr. Jackie Fairley, said, “We are delighted to be working with Ansell, one of the world’s leading protection companies, to bring this highly innovative product to the North American market. We look forward to making it available to consumers and to subsequent launches around the world.”

Having been granted a medical device license for the VivaGel condom after an intensive approval process by the Canadian regulatory authority, Health Canada, LifeStyles Dual Protect will become available for the first time in Canada via Initially launched in Australia, regulatory reviews continue in a number of geographic regions, with further approvals anticipated for this innovative technology in the coming months.

LifeStyles Dual Protect 10-count packs are available for purchase on  All LifeStyles Condoms are triple tested to meet the highest reliability standards. LifeStyles Condoms are available online in addition to a wide range of big box retailers, drugstores, grocery and convenience stores across North America.

About Ansell
Ansell is a world leader in providing superior health and safety protection solutions that enhance human well-being. With operations in North America, Latin America/Caribbean, EMEA and Asia, Ansell employs nearly 15,000 people worldwide and holds leading positions in the personal protective equipment and medical gloves market, as well as in the sexual health and well-being category worldwide. Ansell operates in four main business segments: Medical, Industrial, Single Use and Sexual Wellness. Information on Ansell and its products can be found at

Ansell, ® and TM are trademarks owned by Ansell Limited or one of its affiliates. US Patented and US and non-US Patents Pending: © 2017 Ansell Limited. All Rights Reserved.

About Starpharma
Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY), located in Melbourne Australia, is an ASX 300 company and is a world leader in the development of dendrimer products for pharmaceutical, life science and other applications.

Starpharma’s underlying technology is built around dendrimers – a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical and medical uses.  Starpharma has three core development programs: VivaGel® portfolio, DEP™ drug delivery, and agrochemicals with the Company developing a number of products internally and others via commercial partnerships. For more information please visit:

About cjasher (1591 Articles)
C.J. Asher is a blogger on various subject matters and trending topics related to sexuality, such as prostitution, women's rights, sex trafficking and LGBT issues as well as the adult entertainment industry, having interviewed celebrities such as Dennis Hof and Joanna Angel. C.J. currently resides in Philadelphia, PA and his blog can be found at

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: